ESTEVE'S EXPANSION AND GROWTH IN EU AND USA ACCELERATES ITS TRANSFORMATION INTO A GLOBAL HEALTHCARE COMPANY

New assets in both businesses – Pharma and CDMO – fuel double-digit growth in net revenues and EBITDA and prove strong strategy execution Targeted acquisition and rapid integration expand ESTEVE pharma business portfolio with eight new products in the last 18 months CDMO business grows...